tiprankstipranks
Marizyme Incorporated (MRZM)
OTHER OTC:MRZM
US Market

Marizyme (MRZM) Income Statement

4 Followers

Marizyme Income Statement

Last quarter (Q ), Marizyme's total revenue was $184.74K, an increase of 198.89% from the same quarter last year. In Q, Marizyme's net income was $-20.58M. See Marizyme’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 485.39K$ 233.49K$ 210.28K$ 197.14K$ 0.00$ 20.19K
Cost of Revenue
$ 5.02M$ 54.32K$ 80.35K$ 58.29K$ 0.00$ 20.07K
Gross Profit
$ -4.73M$ 179.17K$ 129.93K$ 138.84K$ 0.00$ 113.00
Operating Expense
$ -21.52M$ 37.50M$ 8.95M$ 5.94M$ 1.06M$ 247.24K
Operating Income
$ -6.79M$ -37.32M$ -8.82M$ -5.80M$ -1.06M$ -247.13K
Net Non Operating Interest Income Expense
$ 1.36M-$ -1.51M$ -45.45K$ 0.00$ -4.61K
Other Income Expense
$ 41.27M$ 25.19M$ 663.52K--$ 3.00K
Pretax Income
$ -43.72M$ -38.17M$ -11.00M$ -5.85M$ -1.06M$ -248.74K
Tax Provision
$ 1.66M$ -1.66M----
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -43.72M$ -38.17M$ -11.00M$ -5.85M$ -1.06M$ -248.74K
Basic EPS
$ -1.16$ -0.94$ -0.31$ -0.22$ -0.05$ -0.04
Diluted EPS
$ -0.58$ -0.94$ -0.31$ -0.22$ -0.05$ -0.04
Basic Average Shares
$ 165.50M$ 40.73M$ 36.04M$ 26.37M$ 19.81M$ 6.67M
Diluted Average Shares
$ 124.77M$ 40.73M$ 36.04M$ 26.37M$ 19.81M$ 6.67M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -16.50M$ 37.56M$ 9.03M$ 6.00M$ 1.06M$ 267.32K
Net Income From Continuing And Discontinued Operation
$ -48.25M$ -38.17M$ -11.00M$ -5.85M$ -1.06M$ -248.74K
Normalized Income
$ -1.55M$ -15.42M-$ -5.85M$ -1.06M$ -248.74K
Interest Expense
$ 810.60K--$ 45.45K$ 0.00$ 4.61K
EBIT
$ -45.08M$ -38.17M$ -9.48M$ -5.80M$ -1.06M$ -244.13K
EBITDA
$ -44.45M$ -37.32M$ -9.44M$ -5.21M$ -1.06M$ -244.13K
Currency in USD

Marizyme Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis